Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified
Conditions
Interventions
Intervention1: Individualized homeopathic
medicines in centesimal
potencies: Intervention is planned as administering indicated homoeopathic medicines in centesimal potencies (CH). Each dose will cons
dosage and repetition depending upon the individual requirement of the cases. Patients will be advised to refrain from handling the globules or from eating, drinking, smoking or brushing teeth within
Sponsors
D N De Homoeopathic Medical College and Hospital
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patient with grade I and II NAFLD established by ultrasound and altered liver enzyme (serum ALT level >=40 IU/L) [ICD-10 code: K 76.0]. 2. Age between 18 and 65 years. 3. Participants of either sex and transgender. 4. Literate patients; ability to read English and/or Bengali and/or Hindi; Illiterate people will be interviewed by the investigators maintaining adequate privacy to fill up the questionnaires. 5. Providing with written informed consent voluntarily to participate.
Exclusion criteria
Exclusion criteria: 1. Regular or excessive use of alcohol and any other addiction. 2. History of chronic liver disease (Viral hepatitis B or C, autoimmune hepatitis). 3. Cholestatic and metabolic liver diseases, hepatic steatosis., hemochromatosis and liver transplants. 4. Combined with uncontrolled diabetes, uncontrolled hypertension, uncontrolled hypothyroidism, kidney or heart disease, stroke or any other severe systemic diseases affecting quality of life. 5. Person under corticosteroid therapy, substance abuse. 6. Vulnerable population â?? unconscious, non-ambulatory, too sick for consultation, differently abled, terminally ill or critically ill, mentally incompetent people. 7. Pregnant and puerperal women and lactating mother. 8. Self-reported immune-compromised state. 9. Already undergoing homoeopathic treatment within last 3 months for any other disease. 10. Simultaneous participation in any other trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum ALT levelTimepoint: At baseline and after 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood Lipid ProfileTimepoint: At baseline and after 3 months;Chronic Liver Disease Questionnaire (CLDQ)Timepoint: At baseline, and every month, up to 3 months of intervention;Measure Yourself Medical Outcome Profile v2 (MYMOP-2) questionnaireTimepoint: At baseline, and every month, up to 3 months of intervention;Serum AST levelTimepoint: At baseline and after 3 months;USG featuresTimepoint: At baseline and after 3 months | — |
Countries
India
Contacts
Public ContactSanjib Sarkar
D N De Homoeopathic Medical College and Hospital
Outcome results
None listed